Fingerprint
Dive into the research topics of 'A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer
Clinton Yam, Gaiane M. Rauch, Tanbin Rahman, Meghan Karuturi, Elizabeth Ravenberg, Jason White, Alyson Clayborn, Pamela McCarthy, Sausan Abouharb, Bora Lim, Jennifer K. Litton, David L. Ramirez, Sadia Saleem, James Stec, W. Fraser Symmans, Lei Huo, Senthil Damodaran, Ryan Sun, Stacy L. Moulder
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations